King Pharmaceuticals

King Pharmaceuticals are a vertically integrated pharmaceutical company that manufactures, markets and sells primarily branded prescription pharmaceutical products. Through a national sales force of over 200 representatives, we marketour branded pharmaceutical products to general/family practitioners and internal medicine physicians and hospitals across the country. King Pharmaceuticals business strategy is to acquire established branded pharmaceutical products and to increase their sales by focused marketing and promotion and through product life cycle management.

Contact Details: 501 Fifth Street Bristol Tennessee 37620 United States of America Tel: 1 (888) 840-5370 Fax: 1 (866) 990-0545 Email: WWW: kingpharm.com/kingpharm/

Loading...

Recent Publications by King Pharmaceuticals:
Further removal of factor v related antigen from bovine thrombin by utilizing a membrane-filtration step. Topical bovine thrombin is commonly used during surgery to maintain...	28th May, 2008	King Pharmaceuticals Inc., 2228 Pleasant View Road, Middleton, WI, USA.	Clin Appl Thromb Hemost. 2008 Apr;14(2):135-40. Epub 2007 Dec 26. DOI Direct Link
Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers. BACKGROUND: Binodenoson, a highly selective agonist of the adenosine A 2A...	13th July, 2005	King Pharmaceuticals Research & Development Inc., 400 CentreGreen Way,	J Nucl Cardiol. 2005 Mar-Apr;12(2):166-71.

BioNews Results for King Pharmaceuticals:
King Pharmaceuticals (NYSE:KG) Has Agreed To Settle Also The Shareholder Derivative Lawsuit	PR inside:  Aug 31 2008 6:36AM Matching: king pharmaceuticals
KING PHARMACEUTICALS INC EPS Estimated At 1.85: Current Recommendation is Neutral	Calibre Macro World:  Aug 30 2008 1:39PM Matching: king pharmaceuticals
KING PHARMACEUTICALS INC EPS Estimated At 1.85: Current Recommendation is Neutral	Macro World Investor:  Aug 30 2008 1:30PM Matching: king pharmaceuticals
King Proposes Acquisition of Alpharma	PharmaceuticalProcessing:  Aug 28 2008 11:38PM Matching: king pharmaceuticals
Zacks Analyst Blog Highlights: McDonald's Corp., King Pharmaceuticals, Inc., Alpharma Inc., Entergy Corp. and	SmartBrief:  Aug 29 2008 12:15PM Matching: king pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more King Pharmaceuticals news.

King Pharmaceuticals Patents:
US Patent No.	Title
7342003	Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
6248774	Method for treating hyper-excited sensory nerve functions in humans
6326390	Use of adenosine A3 receptor antagonists to inhibit tumor growth
6358964	Adenosine, A3 receptor modulators
6368573	Diagnostic uses of 2-substituted adenosine carboxamides
→View more King Pharmaceuticals patents.

King Pharmaceuticals (KG) Financial information Links from Barchart
KG Quote from from Barchart.com
KG Chart from from Barchart.com
KG Profile from from Barchart.com
KG Opinion from from Barchart.com
→View more King Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 203 times since April 2007, the link to the organisation's website has been followed 24 times

Recent Search Terms used to find this page: king pharmaceuticals middleton wi | King Pharmaceuticals | Binodenoson | King pharmaceuticals AND earnings call AND 2005 | king binodenoson | binodenoson 2008 | binodenoson King Pharmaceuticals | .

Search for more companies in Bristol

Search for more companies in Tennessee

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for King Pharmaceuticals